Abstracts tagged "connective tissue diseases and systemic sclerosis"

Abstract Number: 1885 • 2016 ACR/ARHP Annual Meeting
Can Nailfold Videocapillaroscopy Images be Interpreted Reliably By Different Observers? Results of an Inter-Reader and Intra-Reader Exercise Among Rheumatologists with Different Experience in This Field
Tatiana Sofia Rodriguez-Reyna¹, Chiara Bertolazzi², Angelica Vargas Guerrero³, Marwin Gutierrez⁴, Gabriela Hernandez-Molina⁵, Marcelo Audisio⁶, Susana Roverano⁷, Margarita González de Urizar⁸, José Francisco Díaz Coto⁹, Blanca Herrera Velasco¹⁰, Mijahil Cornejo Ortega¹¹, Ana María Sapag Durán¹², Janeth Villegas Guzmán¹³, Luìs Fernando Medina Quintero¹⁴, Mirtha Sabelli¹⁵, Carlos Velasquez¹⁶, Sandy Sapag Durán¹⁷, Oscar Sedano¹⁸, Martín Zapata Zúñiga¹⁹, Maria Fonseca²⁰, Maurizio Cutolo²¹ and PANLAR Capillaroscopy Group, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Instituto Nacional de Rehabilitación, Mexico, Mexico, ⁵Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico City, Mexico, ⁶Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba, Argentina, ⁷Rheumatology, Hospital Jose Maria Cullen, Santa Fe, Argentina, ⁸Rheumatology, Hospital San Ramón, Ciudad del Este, Paraguay, ⁹Rheumatology, Hospital Clínica Bíblica, San José, Costa Rica, ¹⁰Rheumatology, Universidad de San Fancisco Xavier de Chuquisaca, Sucre, Bolivia (Plurinational State of), ¹¹Rheumatology, Hospital Nacional Arzobispo Loayza, Lima, Peru, ¹²Rheumatology, Hospital Universitario Japonés, Santa Cruz, Bolivia (Plurinational State of), ¹³Rheumatology, Hospital Nacional Dos de Mayo, Lima, Peru, ¹⁴Internal Medicine, Universidad del Valle, Cali, Colombia, ¹⁵Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, ¹⁶Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia, ¹⁷Reumatología, Instituto de Investigación en Reumatología Sapag & Sapag, Santa Cruz de la Sierra, Bolivia (Plurinational State of), ¹⁸Rheumatology, Hospital Marino Molina Scippa ESSALUD, Lima, Peru, ¹⁹Rheumatology, Hospitl General Jerez, Jerez, Mexico, ²⁰Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ²¹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy
Background/Purpose: Nailfold videocapillaroscopy (VCP) has become an established method to assess the microcirculation in patients with Raynaud’s phenomenon and connective tissue diseases. The 2013 Systemic…
Abstract Number: 3079 • 2015 ACR/ARHP Annual Meeting
Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD)
Christopher P. Denton¹, J. Gerry Coghlan², Hossein-Ardeschir Ghofrani³, Friedrich Grimminger³, Jianguo He⁴, Gabriela Riemekasten⁵, Dario Vizza⁶, Annette Boeckenhoff⁷, Christian Meier⁸, Janethe de Oliveira Pena⁹ and Marc Humbert¹⁰, ¹Centre for Rheumatology and Connective Tissue Disease, UCL Medical School Royal Free Campus, London, United Kingdom, ²Royal Free London NHS Foundation Trust, London, England, ³University of Giessen and Marburg Lung Center, Giessen, Germany, ⁴Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, ⁵Clinic of Rheumatology and Clinical Immunology, Berlin, Germany, ⁶La Sapienza University of Rome, Rome, Italy, ⁷Bayer Pharma AG, Wuppertal, Germany, ⁸Bayer Pharma AG, Berlin, Germany, ⁹Bayer HealthCare Pharma, Whippany, NJ, ¹⁰Université Paris-Sud, Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique, and INSERM Unité 999, Le Kremlin–Bicêtre, France
Background/Purpose: PAH associated with CTD (PAH-CTD) has a worse prognosis than idiopathic/familial PAH. Here we report a prospective subgroup analysis of patients with PAH-CTD from…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].